1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Smith, J.W. Le Calvez, H. Parra-Gessert, L. Preece, N.E. Jia, X. Assa-Munt, N. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C2 H4 O 44.053 ACETYL GROUP non-polymer C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 277 10298 10305 10.1074/jbc.M108071200 11748219 Selection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3. 2002 10.2210/pdb1i98/pdb pdb_00001i98 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1505.774 ION-SELECTIVE LIGAND D18 1 syn polymer no yes (ACE)CRWLRGDWRQC(NH2) XCRWLRGDWRQCX A polypeptide(L) n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_site repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-07-10 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id NMR Ensemble of Ion-Selective Ligand A1 for Platelet Integrin alphaIIb-beta3 NMR ENSEMBLE OF ION-SELECTIVE LIGAND A22 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 NMR ENSEMBLE OF ION-SELECTIVE LIGAND D16 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 RCSB Y RCSB 2001-03-18 REL REL The peptide was chemically synthesized: Commercial solid phase with cyclization with selective disulphide oxidation. sample THE ENSEMBLE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR NMR TECHNIQUES (CIRCA 2000) structures with the lowest energy 200 15 NOESY & DQF-COSY 10mM PHOSPHATE/5% D2O 6.50 1 atm 278.00 K ENSEMBLE D18 IS BASED ON A TOTAL OF 70 NOE-DERIVED DISTANCE CONSTRAINTS, 8 DIHEDRAL ANGLE RESTRAINTS, 1 COVALENT ACE-CYS-SS-CYS BOND AND 1 LRGD I,I+3 HYDROGEN BOND RESPECTIVELY. REFINEMENTS INCORPORATED ALPHA PROTON AND ALPHA, BETA CARBON SHIFTS OF 10 RESIDUES. RESTRAINED MOLECULAR DYNAMICS AND CHEMICAL SHIFT REFINEMENT. 3MG D18/ML BRUNGER A. NILGES M. (KUSZWESKI J. CLORE G.M.) refinement X-PLOR 3.8.5.1 (CHEM.SHIFT.MODULE) VARIANINC collection VNMR 6.1B HARE D. > BIOSYM > MSI data analysis Felix 2000 500 Varian UNITYPLUS ACE 1 n 1 ACE 1 A CYS 2 n 2 CYS 2 A ARG 3 n 3 ARG 3 A TRP 4 n 4 TRP 4 A LEU 5 n 5 LEU 5 A ARG 6 n 6 ARG 6 A GLY 7 n 7 GLY 7 A ASP 8 n 8 ASP 8 A TRP 9 n 9 TRP 9 A ARG 10 n 10 ARG 10 A GLN 11 n 11 GLN 11 A CYS 12 n 12 CYS 12 A CYS 12 n 13 NH2 13 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 3 0.312 SIDE CHAIN 1 A ARG 6 0.300 SIDE CHAIN 1 A ARG 10 0.306 SIDE CHAIN 2 A ARG 3 0.292 SIDE CHAIN 2 A ARG 6 0.305 SIDE CHAIN 2 A ARG 10 0.276 SIDE CHAIN 3 A ARG 3 0.310 SIDE CHAIN 3 A ARG 6 0.313 SIDE CHAIN 3 A ARG 10 0.308 SIDE CHAIN 4 A ARG 3 0.279 SIDE CHAIN 4 A ARG 6 0.243 SIDE CHAIN 4 A ARG 10 0.260 SIDE CHAIN 5 A ARG 3 0.316 SIDE CHAIN 5 A ARG 6 0.302 SIDE CHAIN 5 A ARG 10 0.262 SIDE CHAIN 6 A ARG 3 0.316 SIDE CHAIN 6 A ARG 6 0.314 SIDE CHAIN 6 A ARG 10 0.242 SIDE CHAIN 7 A ARG 3 0.245 SIDE CHAIN 7 A ARG 6 0.306 SIDE CHAIN 7 A ARG 10 0.290 SIDE CHAIN 8 A ARG 3 0.287 SIDE CHAIN 8 A ARG 6 0.289 SIDE CHAIN 8 A ARG 10 0.272 SIDE CHAIN 9 A ARG 3 0.291 SIDE CHAIN 9 A ARG 6 0.298 SIDE CHAIN 9 A ARG 10 0.258 SIDE CHAIN 10 A ARG 3 0.304 SIDE CHAIN 10 A ARG 6 0.317 SIDE CHAIN 10 A ARG 10 0.302 SIDE CHAIN 11 A ARG 3 0.301 SIDE CHAIN 11 A ARG 6 0.313 SIDE CHAIN 11 A ARG 10 0.253 SIDE CHAIN 12 A ARG 3 0.317 SIDE CHAIN 12 A ARG 6 0.317 SIDE CHAIN 12 A ARG 10 0.316 SIDE CHAIN 13 A ARG 3 0.315 SIDE CHAIN 13 A ARG 6 0.314 SIDE CHAIN 13 A ARG 10 0.249 SIDE CHAIN 14 A ARG 3 0.309 SIDE CHAIN 14 A ARG 6 0.317 SIDE CHAIN 14 A ARG 10 0.209 SIDE CHAIN 15 A ARG 3 0.300 SIDE CHAIN 15 A ARG 6 0.230 SIDE CHAIN 15 A ARG 10 0.314 SIDE CHAIN 1 A ASP 8 -98.18 -157.49 1 A ARG 10 -71.84 -167.33 1 A GLN 11 -56.09 -175.82 2 A TRP 4 -115.16 53.46 2 A LEU 5 -91.93 52.97 2 A ASP 8 38.41 32.89 3 A ARG 3 -122.46 -82.88 3 A LEU 5 -91.12 59.25 3 A ASP 8 64.08 -151.08 3 A ARG 10 -89.36 46.19 4 A TRP 9 -91.35 -105.64 4 A ARG 10 -101.36 47.50 5 A ASP 8 55.58 -89.34 7 A LEU 5 -112.72 64.45 7 A ASP 8 64.89 -72.96 8 A TRP 9 -101.11 -78.81 9 A TRP 4 -155.86 -156.57 9 A LEU 5 -77.76 -145.02 9 A ASP 8 60.98 -138.74 10 A ARG 3 -118.91 66.45 10 A LEU 5 -101.53 53.63 10 A ASP 8 55.92 81.38 10 A TRP 9 -101.02 -155.79 10 A ARG 10 -70.61 -165.56 11 A TRP 4 -117.67 54.13 11 A LEU 5 -115.82 52.34 12 A LEU 5 -113.05 78.48 12 A ASP 8 39.48 44.08 12 A TRP 9 -78.91 -166.37 13 A LEU 5 -100.77 66.01 14 A ASP 8 -86.55 49.08 15 A ASP 8 -91.47 -147.06 NMR ENSEMBLE OF ION-SELECTIVE LIGAND D18 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 1 N N disulf 2.018 A CYS 2 A SG CYS 2 1_555 A CYS 12 A SG CYS 12 1_555 covale 1.309 both A ACE 1 A C ACE 1 1_555 A CYS 2 A N CYS 2 1_555 covale 1.306 both A CYS 12 A C CYS 12 1_555 A NH2 13 A N NH2 13 1_555 CELL ADHESION INTEGRIN, RGD, CELL ADHESION 1I98 PDB 1 1I98 1 13 1I98 1 13 1I98 A 1 1 13 BINDING SITE FOR RESIDUE ACE A 1 A ACE 1 Software 2 BINDING SITE FOR RESIDUE NH2 A 13 A NH2 13 Software 1 A ASP 8 A ASP 8 2 1_555 A ARG 10 A ARG 10 2 1_555 A CYS 12 A CYS 12 1 1_555 1 P 1